Showing results (231-240 of 242) with videos related to

Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast CancerJoline S J Lim, Andrea L A Wong, Samuel G W Ow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2018
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)Brigette B Y Ma, Wan-Teck Lim, Boon-Cher Goh, et al.
Therapeutic Advances in Medical Oncology|April 18, 2022
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignanciesJingshan Ho, Valerie Heong, Wei Peng Yong, et al.
The Lancet. Oncology|January 18, 2025
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trialWan-Qin Chong, Jia-Li Low, Joshua K Tay, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2021
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefitEmily Nickles, Bhushan Dharmadhikari, Li Yating, et al.
Theranostics|January 12, 2023
FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sitesWin Lwin Thuya, Li Ren Kong, Nicholas L Syn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal CarcinomaWan Qin Chong, Chwee Ming Lim, Arvind Kumar Sinha, et al.
Thyroid : Official Journal of the American Thyroid Association|June 16, 2020
An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid CancerKeith C Bible, Michael E Menefee, Chia-Chi Josh Lin, et al.
Nature Communications|June 8, 2019
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoproteinMin Thura, Abdul Qader Al-Aidaroos, Abhishek Gupta, et al.
Frontiers in Oncology|October 11, 2021
Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine InitiativesSneha Rajiv Jain, Wilson Sim, Cheng Han Ng, et al.
Pageof 25